Nakamura Y, Itoh Y, Wakimoto N, Kanno R, Iida S, Yamamoto K. Successful treatment with bortezomib for POEMS syndrome, overcoming complicated severe heart block. Clinical Case Reports. 2023. 11. 3. e7004
Nakamura Y, Itoh Y, Kakegawa E, Uchida Y, Ichimura T, Sasaki A. BCL6 rearrangements by dual t(3;14)(q27;q32) and t(3;22)(q27;q11) translocations in diffuse large B-cell lymphoma. Journal of clinical and experimental hematopathology : JCEH. 2022. 62. 4. 268-272
Ozaki S, Handa H, Koiso H, Saitoh T, Sunami K, Ishida T, Suzuki K, Narita T, Iida S, Nakamura Y, et al. Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma. Journal of cancer research and clinical oncology. 2022. 148. 1. 191-203
Yamashita T, Takamatsu H, Kawamura K, Sunami K, Hagiwara S, Itagaki M, Takahashi T, Kondo T, Ikeda T, Watanabe-Inamoto K, et al. A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survival. British journal of haematology. 2021. 195. 2. 217-229
Nakamura Y, Okuda I, Uchida Y, Ito Y, Wakimoto N. Pancreatic hyperamylasemia and hyperlipasemia associated with carfilzomib in multiple myeloma. The Annals of pharmacotherapy. 2019. 53. 10. 1067-1068
